Posts Tagged ‘oral obesity medicines’

Right now, we are witnessing a great withdrawal from healthcare, especially for people living with obesity. Many people are losing health insurance coverage altogether because it has become unaffordable. Many others are finding that their insurance will no longer pay for the care they need – if they want the care, they must have the […]

The slate is clean. All is forgiven. We have a fresh new year ahead. So that has us thinking about the trends that are likely to define 2026 in obesity, nutrition, and health. Here are five that floated to the top of our mind. 1. Healthy Weight for Life We have said it before. Weight […]

This year is quickly winding down and with it, some unpleasant memories may, thankfully, fade. But for our interest in obesity and health, 2025 has been a very eventful year of progress, with five milestones that are particular standouts. So let’s pause and celebrate this progress. 1. Global Embrace of Obesity Care Perhaps the biggest […]

News from Lilly about orforglipron this week points to what might be the next big development for GLP-1 medicines. The company announced topline results for a weight maintenance study of orforglipron and this first glimpse has us thinking that maintain might be the magic word in obesity care next year. The topline come from the […]

We’re packing our bags and scanning the meeting app for ObesityWeek in Atlanta, November 4-7. This promises to be a very intense week, with the biggest attendance yet for this signature meeting of the Obesity Society. The agenda for the week has a lot of options and we are still processing them all. But for […]